Filter by: Subject

Results Per Page:

Filter by: Subject

P16 expression (1)
Paediatric HIV cure research (1)
Pain (1)
Palladium (1)
Pancreatic ductal adenocarcinoma (PDA) (1)
Pathogenesis (1)
Patient management (1)
Patient research (1)
Patient surveillance (1)
Patient-to-patient variability (1)
Patients (8)
Patients’ body (1)
Pedometer (1)
Peltophorum africanum (1)
Perception (1)
Peripheral blood (PB) (1)
Personalized therapy (1)
PF4 (1)
Pharmacodynamics (2)
Pharmacogenetics (3)
Pharmacogenomics (2)
Pharmacokinetics (3)
Pharmacology (1)
Pharmacoperones (1)
Phorbol myristate acetate (1)
Physical fitness (1)
Pipiens and molestus forms (1)
Platelet-activating factor (3)
Platelets (3)
Play (1)
Pneumococcai infection (1)
Pneumococcal choline binding protein A (1)
Pneumococcal conjugate vaccines (PCVs) (1)
Pneumococcal disease (1)
Pneumococcal immunization (1)
Pneumococcal infections (2)
Pneumococcal pneumonia (1)
Pneumococcal polysaccharide vaccines (PPVs) (1)
Pneumococcal surface protein A (1)
Pneumococcal surface protein C (1)
Pneumococcus (7)
Pneumolysin (5)
Pneumolysin (PLY) (1)
Pneumolysin antagonists (1)
Pneumonia (2)
Pneumonia -- Treatment (1)
Pneumonia -- Treatment -- South Africa (1)
Pneumonia severity index (PSI) (1)
Pneumonia, Pneumococcal -- Research -- South Africa (1)
Polyhistidine triad proteins (1)
Polymorphisms (1)
Pooled human platelet lysate (pHPL) (1)
Population (1)
Potassium transporters (1)
Potential adjunctive therapies (1)
Power (1)
Precision medicine (1)
Predictive value (1)
Preeclampsia (1)
Pregnancy (3)
Primary health care (PHC) (1)
Primary immunodeficiency disease (PID) (1)
Privacy (2)
Private banks -- South Africa (1)
Procalcitonin (1)
Process assessment (health care) (1)
Progenitor cells (HPC) (1)
Prognosis (1)
Programmed cell death (PCD) (1)
Proliferation (1)
Prophylaxis (1)
Propranolol (1)
Protease-activated receptor 1 (1)
Protein synthesis (1)
Proteinases (1)
Psychotic disorders (1)
Public (1)
Public acceptability (1)
Public umbilical cord blood bank (1)
Pulse generation (1)